X0306 4 2021-06-14 0 0001434316 FATE THERAPEUTICS INC FATE 0001748177 Valamehr Bahram C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 0 1 0 0 Chief Development Officer Common Stock 2021-06-14 4 M 0 16156 2.90 A 111896 D Common Stock 2021-06-14 4 M 0 8844 2.73 A 120740 D Common Stock 2021-06-14 4 S 0 16380 89.1079 D 104360 D Common Stock 2021-06-14 4 S 0 8220 89.6782 D 96140 D Common Stock 2021-06-14 4 S 0 400 90.7575 D 95740 D Stock Option (Right to Buy) 2.90 2021-06-14 4 M 0 16156 0.00 D 2026-01-08 Common Stock 16156 0 D Stock Option (Right to Buy) 2.73 2021-06-14 4 M 0 8844 0.00 D 2027-01-04 Common Stock 8844 111156 D This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020. Represents the weighted average sale price of the shares sold from $88.45 to $89.44 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4. Represents the weighted average sale price of the shares sold from $89.45 to $90.16 per share. Represents the weighted average sale price of the shares sold from $90.71 to $90.86 per share. This option is fully vested. /s/ Cindy Tahl, Attorney-in-Fact 2021-06-16